Theraclion Announces the Evolution of Its Board of Directors

Regulatory News:

THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused Ultrasound (HIFU), announces that Mr. Yann Duchesne has decided not to stand for re-election as Director and Chairman of the Board following the General Meeting held on June 18, 2026, positions he had held since January 24, 2022.

The Company, all members of the Board of Directors and the Executive Management warmly thank Mr. Yann Duchesne for his commitment and the significant contributions he made to the Company throughout his term.

Following the General Meeting held today, the shareholders appointed a new Board of Directors composed of Ms. Lijuan Deng, Mr. Claude Lenoir, Mr. Cédric Bellanger, Mr. Mehdi El Glaoui and Mr. Vincent Gardès, the latter joining the Board of Directors of Theraclion after having served as an observer over recent months.

The new Board of Directors subsequently appointed Mr. Claude Lenoir as Interim Chairman of the Board of Directors, with immediate effect. This appointment ensures continuity of the Company’s governance pending the appointment of a new Chairman.

“I sincerely thank Yann Duchesne for his trust, availability and constant commitment alongside Theraclion. His experience and high standards played an important role in shaping the Company’s strategic direction, its international expansion and its organisational development, helping to build solid foundations for the next stages of its growth. I also thank Claude Lenoir for agreeing to serve as Interim Chairman of the Board of Directors, and I am confident in the future evolution of Theraclion’s governance.” stated Martin Deterre, Chief Executive Officer of Theraclion.

Biography of Yann Duchesne

Yann Duchesne is an experienced French business leader and former Managing Partner of McKinsey & Company France. He has advised numerous major French and international companies on growth, transformation and organizational strategy. He subsequently held responsibilities in private equity in London, before serving in senior executive roles in industry. Over the past twenty years, he has served on numerous boards of directors of listed and private equity-backed companies, often as Chairman.

Schreibe Deinen Kommentar